Activated protein C resistance in preeclampsia

Clinical and Experimental Obstetrics and Gynecology

Volumn 31, Issue 1, 2004, Pages 59-62

  Cagirgan, S ^a   Donmez, A ^a   Ispahi, C ^b  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Ege Maternity Hospital   (Turkey)

Author keywords

Activated protein C resistance; Preeclampsia; Pregnancy

Indexed keywords

ACTIVATED PROTEIN C;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE ASSOCIATION; FEMALE; HEMOSTASIS; HUMAN; PARTIAL THROMBOPLASTIN TIME; PATHOGENESIS; PREECLAMPSIA; THROMBOEMBOLISM;

ACTIVATED PROTEIN C RESISTANCE; ADULT; COMORBIDITY; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY;

EID: 1042265328     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Rotmensch S., Liberati M., Mittelman M., Rafeal Z.: "Activated protein C resistance and adverse pregnancy outcome". Am. J. Obstet. Gynecol., 1997, 177, 170.
2. Krauss T., Augustin H., Osmers R., Meden H., Unterhalt M., Kuhn W.: "Activated protein C resistance and factor V Leiden in patients with hemolysis, elevated liver enzymes, low platelets syndrome". Obstet. Gynecol., 1998, 92, 457.
3. Perry G., Martin N.: "Abnormal hemostasis and coagulopathy in preeclampsia and eclampsia". Clin. Obstet. Gynecol., 1992, 35, 338.
4. Dekker G.A., de Vries J.I.P., Doclittzsch P., Huijgens P., von Blomberg B., Jakobs C., van Geijn H.: "Underlying disorders associated with severe early-onset preeclampsia". Am. J. Obstet. Gynecol., 1995, 173, 1042.
5. van Beck E., Peeters H.: "Pathogenesis of preeclampsia: A comprehensive model". Obstet. Gynecol. Surveys, 1998, 53, 233.
6. Perry G., Martin N.: "Abnormal hemostasis and coagulopathy in preeclampsia and eclampsia". Clin. Obstet. Gynecol., 1992, 35, 338.
7. Hung C., Yang Z.: "The predictive value of the hemostasis parameters in the development of preeclampsia". Thromb. Haemost. 1992, 67, 214.
8. Dahlback B., Carlsson M., Svensson P.: "Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C". Proc. Natl. Acad. Sci., 1993, 90, 1004.
9. Dahlback B.: "Inherited thrombophilia: Resistance to activated protein C as a basis for venous thrombosis". Blood. 1995, 85, 607.
10. 506Q mutation in the gene for factor V is a common risk factor for venous thrombosis". J. Inter. Med., 1997, 242, 1.
11. Rosen S., Sturk A.: "Activated protein C resistance - A major risk factor for thrombosis". Eur. J. Clin. Chem. Clin. Biochem., 1997, 35 (7), 501.
12. Dizon D., Nelson L., Easton K., Ward K.: "The factor V Leiden mutation may predispose women to severe preeclampsia". Am. J. Obstet. Gynecol., 1996, 175, 902.
13. Nagy B., Toth T., Rigo J., Karadi I., Romics L., Papp Z.: "Detection of factor V Leiden mutation in severe pre-eclamptic Hungarian women" (abstr.). Clin. Genet., 1998, 53, 478.
14. Cetin M., Gucer S., Serin S.: "Activated protein C resistance in Turkish women with severe preeclampsia". Gynecol. Obstet. Invest., 2001, 52, 168.
15. Paternoster D., Stella A., Simioni P.: "Activated protein C resistance in normal and pre-eclamptic pregnancies". Gynecol. Obstet. Invest., 2002, 54, 145.
16. Higgins JR., Walshe JJ., Darling MR, et al.: "Hemostasis in the uteroplacental and peripheral circulations in normatensive and pre-eclamptic pregnancies". Am. J. Obstet. Gynecol., 1998, 179 (2), 520.
17. Salafia C.M., Pezullo J.C., Lopez-Zeno J.A., Simmens S., Minior V.K., Vintzileos A.M.: "Placental pathologic features of preterm preeclampsia". Am. J. Obstet. Gynecol., 1995, 173 (4), 1097.
18. Lindoff C., Ingemarsson I., Martinsson G., Segelmark M., Thysell H., Astedt B.: "Preeclampsia is associated with a reduced response to activated protein C". Am. J. Obstet. Gynecol., 1997, 176, 457.
19. Pampus M., Dekker G., Wolf W., Huijgens P., Koopman M., Blomberg M., Büller H.: "High prevalence of hemostatic abnormalities in women with a history severe preeclampsia". Am. J. Obstet. Gynecol., 1999, 180, 1146.
20. Koster T., Rosendaal F.R., de Ronde H., Briet E., Vondenbroucke J.P., Bertina R.: "Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study". Lancet, 1993, 342, 1503.
21. Griffin J.H., Evatt B., Widerman C., Fernandez J.A.: "Anticoagulant protein C pathway defective in majority of thrombophilic patients". Blood, 1993, 82, 1989.
22. Bertina R., Koeleman B., Koster T., Rosendaal F., Dirven R., Ronde H., Veiden P., Reltsma P.: "Mutation in blood coagulation factor V associated with resistance to activated protein C". Nature, 1994, 369, 64.
23. Svensson P.J., Dahlback B.: "Resistance to activated to protein C as a basis for venous thrombosis". N. Engl. J. Med., 1994, 330, 517.
24. Dahlback B.: "Inherited thrombophilia: Resistance to activated protein C as a basis for venous thrombosis". Blood, 1995, 85, 607.
25. Rees D.C., Cox M., Clegg J.B.: "World distribution of factor V Leiden". Lancet, 1995, 346, 1133.
26. Gurgey A., Mesci L.: "The prevalence of factor V Leiden (1691 G-A) mutation in Turkey". Turk. J. Pediatr., 1997, 39 (3), 313.
27. Hellgran M., Svenson P.J., Dahlback B.: "Resistance to activated to protein C as a basis for venous thrombosis associated with pregnancy and oral contraceptives". Am. J. Obstet. Gynecol., 1995, 173, 210.
28. Vanderbroucke J.P., Koster T., Brict E., Reitsma P.H., Bertina R.M., Rosendaal F.: "Increased risk of venous thrombosis in oral contraceptive users who are carrier of factor V Leiden mutation". Lancet, 1994, 344, 1453.
29. Letsky E.A.: Coagulation defects. In: De Swiet M. (ed.) Medical Disorders in Obstetric Practice. Oxford, Blackwell Science, 1995, 71.
30. 506) and pregnancy". Thromb. Haemost., 1999, 81, 532.
31. Bokarewa M., Bremme K., Blomback M., Büller H., Berends F., ten Cate J.W. et al.: "Arg 506-Gln mutation in factor V and risk of thrombosis during pregnancy". Br. J. Haematol., 1996, 92, 473.
32. Kjellberg U., Andersson N.E., Rosen S., Tengborn L., Hellgren M.: "APC resistance and other haemostatic variables during pregnancy and puerperium". Thromb Haemost., 1999, 81, 527.
33. Vasse M., Leduc O., Borg J.Y., Chretien M.H., Monconduit M.: "Resistance to activated protein C: evaluation of three functional assays". Thromb. Res., 1994, 76, 47.
34. Peek M.J., Nelson-Pierey C., Manning R.A., Swiet M., Letsky E.A.: "Activated protein C in normal pregnancy". Br. J. Obstet. Gynaecol., 1997, 104, 1084.